Crossmark

A method for identifying genetic heterogeneity within phenotypically defined disease subgroups

Crossref DOI link: https://doi.org/10.1038/ng.3751

Published Online: 2016-12-26

Published Print: 2017-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liley, James

Todd, John A

Wallace, Chris https://orcid.org/0000-0001-9755-1703
License Information

Text and Data Mining valid from 2016-12-26
More Information

Article History

Received: 2 August 2016

Accepted: 23 November 2016

First Online: 26 December 2016

Competing interests

: The JDRF-Wellcome Trust Diabetes and Inflammation Laboratory receives funding from Hoffmann La Roche and Eli Lilly and Company.